10,000+ stock pitches from top investors available on joinyellowbrick.com
RA CAPITAL MANAGEMENT, L.P. 13F Holdings
Holdings from the most recent 13F from RA CAPITAL MANAGEMENT, L.P.
Filed: 2022-08-15 (Q2 2022) | Holdings: 88 | Value: $3.8B | Filing Link
PREMIUM
Author Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Filing Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Holding Returns | |||||||
|---|---|---|---|---|---|---|---|
| Stock | Put/Call | Change | Holding Pct | Value | Current Return | 3M Return | 1Y Return |
| ASND - ASCENDIS PHARMA A/S | 18.76% | $703.5M | +64.92% | +6.68% | -16.50% | ||
| BIIB - BIOGEN INC | 3.95% | $148.3M | -41.21% | +35.30% | +19.63% | ||
| CTKB - CYTEK BIOSCIENCES INC | 3.83% | $143.6M | -77.51% | -1.82% | -43.74% | ||
| AVTE - AEROVATE THERAPEUTICS INC | 3.44% | $129.2M | -19.35% | -38.83% | |||
| DAWN - DAY ONE BIOPHARMACEUTICALS I | Add 16% ($17.6M) | 3.36% | $126.0M | -72.21% | -15.19% | -46.22% | |
| TVTX - TRAVERE THERAPEUTICS INC | 3.18% | $119.3M | -48.08% | -25.36% | -48.22% | ||
| JANX - JANUX THERAPEUTICS INC | 2.82% | $105.9M | +70.88% | +8.35% | -22.84% | ||
| PCVX - VAXCYTE INC | 2.66% | $99.7M | +34.41% | +67.44% | +83.16% | ||
| IMGN - IMMUNOGEN INC | 2.61% | $97.8M | -10.52% | +177.41% | |||
| NKTX - NKARTA INC | Add 39% ($27.1M) | 2.56% | $96.2M | -89.92% | -45.93% | -89.21% | |
| BLU - BELLUS HEALTH INC NEW | 2.52% | $94.5M | -21.88% | ||||
| ITOS - ITEOS THERAPEUTICS INC | 2.43% | $91.0M | -59.92% | -14.96% | -54.53% | ||
| VERU - VERU INC | New Purchase | 2.38% | $89.3M | -96.94% | -69.12% | -94.52% | |
| DICE - DICE THERAPEUTICS INC | 2.16% | $80.8M | +53.59% | ||||
| PEPG - PEPGEN INC | New Purchase | 2.15% | $80.8M | -86.68% | +40.62% | -43.06% | |
| FMTX - FORMA THERAPEUTICS HLDGS INC | 1.66% | $62.1M | |||||
| ACRS - ACLARIS THERAPEUTICS INC | Add 142% ($36.0M) | 1.64% | $61.4M | -90.69% | +7.22% | -53.94% | |
| PNT - POINT BIOPHARMA GLOBAL INC | 1.63% | $61.3M | -31.83% | -12.98% | |||
| CLDX - CELLDEX THERAPEUTICS INC NEW | 1.49% | $55.9M | -46.67% | -5.95% | -17.67% | ||
| WVE - WAVE LIFE SCIENCES LTD | New Purchase | 1.49% | $55.9M | +95.65% | -3.48% | +24.64% | |
| VOR - VOR BIOPHARMA INC | 1.47% | $55.3M | -95.87% | -16.93% | -46.10% | ||
| KNTE - KINNATE BIOPHARMA INC | 1.43% | $53.8M | -34.53% | -83.95% | |||
| TYRA - TYRA BIOSCIENCES INC | 1.38% | $51.7M | -13.52% | -35.63% | +26.62% | ||
| GHRS - GH RESEARCH PLC | Add 1% ($709.0K) | 1.30% | $48.9M | -14.04% | -26.45% | -25.09% | |
| GERN - GERON CORP | 1.25% | $46.7M | -33.90% | -5.08% | +14.41% | ||
| NTRA - NATERA INC | 1.24% | $46.4M | +192.42% | -35.11% | -5.81% | ||
| ABOS - ACUMEN PHARMACEUTICALS INC | 1.22% | $45.9M | -79.66% | +16.92% | +29.09% | ||
| NSTG - NANOSTRING TECHNOLOGIES | New Purchase | 1.21% | $45.5M | -56.54% | -82.84% | ||
| RXST - RXSIGHT INC | 1.15% | $43.0M | +7.34% | +0.36% | +117.84% | ||
| ENTA - ENANTA PHARMACEUTICALS INC | Reduce 7% $(3.2M) | 1.13% | $42.4M | -89.68% | -34.19% | -77.98% | |
| ELYM - ELIEM THERAPEUTICS INC | 1.06% | $39.7M | -56.03% | +2.84% | -7.09% | ||
| RLMD - RELMADA THERAPEUTICS INC | 1.01% | $38.0M | -97.19% | -80.16% | -89.32% | ||
| TIL - INSTIL BIO INC | Add 57% ($12.9M) | 0.94% | $35.4M | -79.08% | -72.83% | -93.24% | |
| ICVX - ICOSAVAX INC | 0.91% | $34.2M | -73.13% | -19.71% | |||
| RNA - AVIDITY BIOSCIENCES INC | 0.84% | $31.5M | +59.60% | -43.14% | -62.38% | ||
| DSGN - DESIGN THERAPEUTICS INC | 0.82% | $30.6M | -84.38% | -48.28% | -91.68% | ||
| ANTX - AN2 THERAPEUTICS INC | Add 2% ($633.4K) | 0.77% | $29.1M | -94.95% | -35.41% | -57.95% | |
| RCKT - ROCKET PHARMACEUTICALS INC | 0.77% | $29.0M | -84.71% | +7.40% | -12.91% | ||
| EYPT - EYEPOINT PHARMACEUTICALS INC | 0.71% | $26.5M | -25.27% | -62.95% | +24.64% | ||
| ETNB - 89BIO INC | New Purchase | 0.67% | $25.1M | +106.21% | +90.48% | +232.71% | |
| STSA - SATSUMA PHARMACEUTICALS INC | New Purchase | 0.65% | $24.5M | -89.64% | |||
| PMVP - PMV PHARMACEUTICALS INC | 0.65% | $24.4M | -94.36% | -38.90% | -56.77% | ||
| VERA - VERA THERAPEUTICS INC | Reduce 20% $(5.3M) | 0.57% | $21.5M | +40.83% | -25.29% | -20.92% | |
| VRNA - VERONA PHARMA PLC | 0.57% | $21.4M | +577.81% | -4.52% | +41.84% | ||
| RYTM - RHYTHM PHARMACEUTICALS INC | 0.54% | $20.2M | +150.11% | -3.21% | -3.78% | ||
| TNYA - TENAYA THERAPEUTICS INC | 0.53% | $20.0M | -90.54% | -44.13% | -32.75% | ||
| DYN - DYNE THERAPEUTICS INC | 0.51% | $19.3M | +17.27% | -18.02% | -11.48% | ||
| HLVX - HILLEVAX INC | New Purchase | 0.51% | $19.2M | -84.29% | +68.27% | -5.45% | |
| GH - GUARDANT HEALTH INC | 0.51% | $19.2M | -11.24% | -9.31% | -35.53% | ||
| PRDS - PARDES BIOSCIENCES INC | 0.51% | $19.0M | -59.86% | -24.73% | |||
| CNTA - CENTESSA PHARMACEUTICALS PLC | Reduce 100% | 0.00% | $0.00 | ||||
| CCXI - CHEMOCENTRYX INC | Reduce 100% | 0.00% | $0.00 | ||||
| KALV - KALVISTA PHARMACEUTICALS INC | Reduce 100% | 0.00% | $0.00 | ||||
| LIAN - LIANBIO | Reduce 100% | 0.00% | $0.00 | ||||
| MGNX - MACROGENICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| MRTX - MIRATI THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| NVAX - NOVAVAX INC | Reduce 100% | 0.00% | $0.00 | ||||